AXSM

74.89

1.53% +1.13

시간 외 거래: 74.86 -0.03 -0.04%

Axsome Therapeutics Inc (AXSM)

개요 뉴스 가격 이력 옵션 체인 AXSM 왜 하락? 토론 예측

전일 마감가:

$73.76

열려 있는:

$74.03

하루 거래량:

453.69K

시가총액:

$3.56B

수익:

$270.60M

순이익/손실:

$-239.24M

주가수익비율:

-16.53

EPS:

-4.53

순현금흐름:

$-145.66M

1주 성능:

+5.23%

1개월 성능:

-2.73%

6개월 성능:

+15.89%

1년 성능:

+5.82%

1일 변동 폭

$73.28

$76.39

52주 변동 폭

$55.02

$98.40

Axsome Therapeutics Inc Stock (AXSM) Company Profile

명칭

Axsome Therapeutics Inc

부문

Healthcare (1189)

산업

Biotechnology (685)

전화

212-332-3241

주소

25 Broadway, 9th Floor, New York

직원

트위터

다음 수익 날짜

2024-05-06

최신 SEC 제출 서류

AXSM's Discussions on Twitter

Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2024-02-06	개시	UBS	Buy
2024-01-25	개시	RBC Capital Mkts	Outperform
2023-12-13	개시	Citigroup	Buy
2023-08-08	업그레이드	BofA Securities	Underperform → Neutral
2023-01-05	개시	Piper Sandler	Neutral
2022-11-01	개시	Loop Capital	Buy
2022-09-07	재개	Mizuho	Buy
2021-08-10	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2021-06-10	개시	Berenberg	Buy
2021-01-08	개시	Jefferies	Buy
2020-12-16	개시	Mizuho	Buy
2020-09-29	개시	BofA Securities	Underperform
2020-09-10	개시	Morgan Stanley	Overweight
2020-04-28	재확인	H.C. Wainwright	Buy
2020-04-14	개시	Cowen	Outperform
2019-12-30	재확인	H.C. Wainwright	Buy
2019-12-17	재확인	H.C. Wainwright	Buy
2019-12-16	재확인	Guggenheim	Buy
2019-10-16	개시	Guggenheim	Buy
2019-09-18	개시	William Blair	Outperform
2019-05-28	개시	SunTrust	Buy
2019-05-23	재확인	H.C. Wainwright	Buy
2019-04-08	개시	SVB Leerink	Outperform
2019-03-15	재확인	H.C. Wainwright	Buy
2016-10-03	재개	Brean Capital	Buy
2015-12-15	개시	Cantor Fitzgerald	Buy
2015-12-14	개시	Ladenburg Thalmann	Buy

모두보기

Axsome Therapeutics Inc 주식(AXSM)의 최신 뉴스

TScan Therapeutics, Inc. (TCRX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Zacks Investment Research

Peeling Back The Layers: Exploring Axsome Therapeutics Through Analyst Insights

Benzinga

Earnings Preview: Axsome Therapeutics (AXSM) Q1 Earnings Expected to Decline

Zacks Investment Research

Billionaires Are Buying These 2 Ultra-High Yield Dividend Stocks Hand Over Fist. Are They Smart Buys for Your Portfolio?

The Motley Fool

Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting

GlobeNewswire Inc.

Alkermes' (ALKS) ALKS 2680 Betters Wakefulness in Phase Ib Study

Zacks Investment Research

Axsome Therapeutics Inc (AXSM) 재무 분석

Axsome Therapeutics Inc (AXSM) 매출 2024

AXSM은 2023-12-31 종료 분기에 대해 매출(지난 12개월)이 270.60M 달러로 보고했습니다.

Axsome Therapeutics Inc (AXSM) 순이익 2024

AXSM은 2023-12-31 종료 분기에 대해 순이익(지난 12개월)이 -239.24M 달러로 보고했으며, 전년대비 -27.84% 감소했습니다.

Axsome Therapeutics Inc (AXSM) 현금흐름 2024

2023-12-31 종료 분기에 AXSM은 현금흐름(지난 12개월)으로 -145.66M 달러를 기록했으며, 전년 대비 -24.27% 감소했습니다.

Axsome Therapeutics Inc (AXSM) 주당 순이익 2024

AXSM이 보고한 2023-12-31 종료 분기의 주당 순이익(지난 12개월)은 -5.20달러이며, 전년 대비 -13.79% 감소했습니다.

Axsome Therapeutics Inc 주식 (AXSM) 내부자 거래

내부자 거래	관계	날짜	거래	비용	#주식	가치 ($)	#주식 총계
Jacobson Mark L.	Chief Operating Officer	Apr 01 '24	Option Exercise	1.30	24,662	32,061	24,662
Jacobson Mark L.	Chief Operating Officer	Apr 01 '24	Sale	77.24	24,662	1,904,942	0
JEFFS ROGER	Director	Mar 15 '24	Option Exercise	29.91	2,347	70,199	123,103
JEFFS ROGER	Director	Mar 15 '24	Sale	71.61	2,347	168,062	120,756
JEFFS ROGER	Director	Mar 14 '24	Option Exercise	24.01	29,976	719,787	137,732
JEFFS ROGER	Director	Mar 14 '24	Sale	69.70	29,976	2,089,387	120,756
Coleman Mark	Director	Sep 15 '23	Option Exercise	3.67	11,016	40,429	36,113
Coleman Mark	Director	Sep 15 '23	Sale	75.18	18,572	1,396,189	403,856
Coleman Mark	Director	Sep 15 '23	Sale	75.19	11,016	828,241	25,097